Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore.
Chin Shern LauMay Lin Helen OhSoon Kieng PhuaYa Li LiangYanfeng LiJianxin HuoYuhan HuangBiyan ZhangShengli XuTar-Choon AwPublished in: Antibodies (Basel, Switzerland) (2022)
The mRNA vaccines generated a more robust S-Ab and N-Ab response than the inactivated virus vaccine at all time points after the first, second, and third vaccinations.